• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4596465)   Today's Articles (4749)   Subscriber (49343)
For: Bradbury BJ, Baumgold J, Paek R, Kammula U, Zimmet J, Jacobson KA. Muscarinic receptor binding and activation of second messengers by substituted N-methyl-N-[4-(1-azacycloalkyl)-2-butynyl]acetamides. J Med Chem 1991;34:1073-9. [PMID: 1848294 DOI: 10.1021/jm00107a029] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Number Cited by Other Article(s)
1
Design and synthesis of new potent N,N -bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents. Eur J Med Chem 2018;147:7-20. [DOI: 10.1016/j.ejmech.2018.01.092] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2017] [Revised: 01/18/2018] [Accepted: 01/28/2018] [Indexed: 01/06/2023]
2
Zhang X, Liu P, Zhu L. Structural Determinants of Alkyne Reactivity in Copper-Catalyzed Azide-Alkyne Cycloadditions. Molecules 2016;21:molecules21121697. [PMID: 27941684 PMCID: PMC6274337 DOI: 10.3390/molecules21121697] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Revised: 12/03/2016] [Accepted: 12/05/2016] [Indexed: 11/16/2022]  Open
3
Nishida H, Miyazaki Y, Kitamura Y, Ohashi M, Matsusue T, Okamoto A, Hosaka Y, Ohnishi S, Mochizuki H. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor. Chem Pharm Bull (Tokyo) 2001;49:1237-44. [PMID: 11605647 DOI: 10.1248/cpb.49.1237] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
4
Kuznetsov SG, Ramsh SM, Zmyvalova AG. Search for selective ligands for muscarinic choline receptors. 1. Muscarinic agonists (review). Pharm Chem J 1995. [DOI: 10.1007/bf02219375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
5
Baumgold J, Dyer K, Falcone JF, Bymaster FP. Comparison of second-messenger responses to muscarinic receptor stimulation in M1-transfected A9 L cells. Cell Signal 1995;7:39-43. [PMID: 7756109 DOI: 10.1016/0898-6568(94)00067-l] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
6
Petric A, Barrio JR. Synthesis and NMR characterization of 4-[(2-tetrahydro-pyranyloxy)methyl]piperidine and intermediates. J Heterocycl Chem 1994. [DOI: 10.1002/jhet.5570310249] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
7
Chapter 3. Recent Advances in the Design and Characterization of Muscarinic Agonists and Antagonists. ANNUAL REPORTS IN MEDICINAL CHEMISTRY 1994. [DOI: 10.1016/s0065-7743(08)60716-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register]
8
Sanders KB, Thomas AJ, Pavia MR, Davis RE, Coughenour LL, Myers SL, Fisher S, Moos WH. Cholinergic agents: aldehyde, ketone, and oxime analogues of the muscarinic agonist UH5. Bioorg Med Chem Lett 1992. [DOI: 10.1016/s0960-894x(00)80535-1] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA